407 related articles for article (PubMed ID: 27130958)
1. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis.
Oh S; Cho S; Moon SY; Lee J; Kim M; Lee TY; Kwon JS
Asian J Psychiatr; 2024 Jan; 91():103847. PubMed ID: 38029602
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
[TBL] [Abstract][Full Text] [Related]
5. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
7. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
8. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
Pittenger C
Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
[TBL] [Abstract][Full Text] [Related]
9. An update on the pharmacological treatment of obsessive-compulsive disorder.
Fontenelle LF; Nascimento AL; Mendlowicz MV; Shavitt RG; Versiani M
Expert Opin Pharmacother; 2007 Apr; 8(5):563-83. PubMed ID: 17376013
[TBL] [Abstract][Full Text] [Related]
10. Drug treatment of obsessive-compulsive disorder.
Kellner M
Dialogues Clin Neurosci; 2010; 12(2):187-97. PubMed ID: 20623923
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.
Fineberg NA; Reghunandanan S; Brown A; Pampaloni I
Aust N Z J Psychiatry; 2013 Feb; 47(2):121-41. PubMed ID: 23125399
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
[TBL] [Abstract][Full Text] [Related]
13. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
16. Issues in the pharmacological treatment of obsessive-compulsive disorder.
Math SB; Janardhan Reddy YC
Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009.
Greil W; Häberle A; Haueis P; Grohmann R; Russmann S
J Affect Disord; 2012 Feb; 136(3):534-42. PubMed ID: 22134044
[TBL] [Abstract][Full Text] [Related]
18. International prescribing practices in obsessive-compulsive disorder (OCD).
Brakoulias V; Starcevic V; Belloch A; Dell'Osso L; Ferrão YA; Fontenelle LF; Lochner C; Marazziti D; Martin A; Matsunaga H; Miguel EC; Reddy YC; do Rosário MC; Shavitt RG; Sundar AS; Stein DJ; Viswasam K
Hum Psychopharmacol; 2016 Jul; 31(4):319-24. PubMed ID: 27271200
[TBL] [Abstract][Full Text] [Related]
19. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of treatment-resistant obsessive-compulsive disorder.
Abudy A; Juven-Wetzler A; Zohar J
CNS Drugs; 2011 Jul; 25(7):585-96. PubMed ID: 21699270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
